Target Area:
Vestibular disorders, motion sickness
Meclizine is a first-generation H₁ antihistamine with a long history of safe and effective use in the treatment of motion sickness and vertigo.
Our capabilities include API manufacturing, salt and polymorph optimization, and impurity management, supporting reliable global pharmaceutical supply chains.
"Aurapha’s science-driven approach to API development demonstrates how rigorous chemistry, process robustness, and regulatory readiness can translate complex molecules into reliable, scalable drug substances."